Sun, June 14, 2026
AUS Edition NZ Edition UK Edition
CA Edition USA Edition IND Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. PLUR
Healthcare
Facebook Twitter Linkedin

Pluri Inc. (NASDAQ:PLUR)

2.27 USD

+0.020 0.889%
Last Updated at: 2026-06-12T20:02:00Z

Pluri Inc.

Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Building No. 5, Haifa, Israel, 3508409

972 74 710 8600

https://www.pluri-biotech.com

Employees: 123

Key Executives

Sr. No. Name Title Year Born
1. Mr. Yaacov Yanay Pres, CEO & Director 1971
2. Ms. Chen Franco-Yehuda CFO, Treasurer & Sec. 1983
3. Mr. Lior Raviv Chief Technology Officer NA
4. Ms. Efrat Livne-Hadass VP of HR NA
5. Dr. Nitsan Halevy M.D. Chief Medical Officer NA
6. Mr. Nimrod Bar Zvi Chief Commercial Officer NA
7. Mr. Yaacov Yanay President, CEO & Director 1971
8. Ms. Chen Franco-Yehuda CFO, Treasurer & Secretary 1984
9. Ms. Efrat Livne-Hadass Vice President of Human Resources NA

Peers

Sector: Healthcare

Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
NVO

Novo Nordisk A/S

 -0.080 0.182% 43.94 41.580 31.153 2.134 32.989 2.113 4.700
NONOF

Novo Nordisk A/S

 +1.990 4.737% 44 41.060 31.250 2.078 33.111 2.113 4.700
VRTX

Vertex Pharmaceuticals Inc

 -0.115 0.026% 440.02 29.670 24.331 10.385 5.832 9.334 20.004
REGN

Regeneron Pharmaceuticals Inc

 +0.660 0.108% 613.11 29.070 20.121 7.570 3.823 6.950 19.423

Income Statement

(Currency in USD)
Breakdown 30-06-2023 30-06-2022 30-06-2021 30-06-2020 30-06-2019
Income Before Tax -28.887M -41.374M -49.865M -29.152M -35.307M
Minority Interest 0.566M 0.132M - - -
Net Income -28.321M -41.023M -49.943M -29.348M -35.213M
Selling General Administrative 11.779M 17.45M 20.557M 7.922M 9.157M
Gross Profit 0.278M -41.359M -50.623M 0.023M 0.052M
Reconciled Depreciation 0.362M 1.053M 1.37M 1.57M 1.962M
Ebit -26.178M -41.593M -50.623M -29.476M -35.532M
Ebitda -25.816M -39.984M -48.784M -27.554M -33.439M
Depreciation And Amortization 0.362M 1.609M 1.839M 1.922M 2.093M
Operating Income -27.246M -41.593M -50.623M -29.476M -35.532M
Other Operating Expenses 27.533M 41.827M 50.623M 29.499M 35.586M
Interest Expense 0.843M 0.887M 0.078M 0.196M 0M
Tax Provision - - - - -
Interest Income 1.084M 0.581M 0.492M 0.384M 0.385M
Net Interest Income 0.225M -0.331M 0.391M 0.156M 0.356M
Income Tax Expense 0.277M -0.351M 0.078M 0.196M -0.094M
Total Revenue 0.287M 0.234M 0M 0.023M 0.054M
Total Operating Expenses 27.524M 41.827M 50.623M 29.499M 35.584M
Cost Of Revenue 0.009M 41.593M 50.623M 0M 0.002M
Total Other Income Expense Net -1.866M 0.219M 0.758M 0.324M 0.225M
Net Income From Continuing Ops -28.887M -41.374M -49.865M -29.152M -35.307M
Net Income Applicable To Common Shares -28.321M -41.242M -49.865M -29.152M -35.307M

Balance Sheet

(Currency in USD)
Breakdown 30-06-2023 30-06-2022 30-06-2021 30-06-2020 30-06-2019
Total Assets 50.797M 68.065M 93.538M 65.532M 31.31M
Intangible Assets - - - - -
Other Current Assets 0.379M 1.41M 0.931M 1.067M 1.245M
Total Liab 35.497M 35.879M 36.387M 9.431M 9.489M
Total Stockholder Equity 13.355M 30.039M 57.151M 56.101M 21.821M
Other Current Liab 3.038M 4.313M 8.317M 4.873M 5.877M
Common Stock - - - - 0.001M
Capital Stock 0M 0M 0M 0M 0.001M
Retained Earnings -399.584M -371.263M -330.021M -280.156M -251.004M
Good Will - - - - -
Other Assets 1.067M 1.309M 23.94M 13.296M 1.101M
Cash 5.36M 9.772M 31.241M 8.27M 4.106M
Cash And Equivalents - - - - -
Total Current Liabilities 5.621M 6.829M 11.517M 7.987M 8.158M
Current Deferred Revenue 0.144M 0.112M 0.04M 0.126M -
Net Debt 24.545M 19.03M -6.657M -6.685M -4.106M
Short Term Debt 0.627M 0.619M 0.634M 1.02M -
Short Long Term Debt - - - - -
Short Long Term Debt Total 29.905M 28.802M 24.584M 1.585M -
Other Stockholder Equity 412.939M 401.302M 387.172M 336.257M 272.824M
Property Plant Equipment 8.321M 9.009M 2.227M 3.775M 3.838M
Total Current Assets 41.409M 57.747M 67.371M 48.461M 26.371M
Long Term Investments - - - - -
Short Term Investments 34.811M 45.244M 33.709M 37.514M 19.599M
Net Receivables 0.527M 1.321M 1.49M 1.61M 1.421M
Long Term Debt 23.53M 21.678M 23.85M - -
Inventory - - - - -
Accounts Payable 1.812M 1.785M 2.526M 1.968M 2.281M
Accumulated Other Comprehensive Income - - - -14.662M -13.166M
Non Currrent Assets Other 1.067M 1.309M 23.94M 13.296M 1.101M
Non Current Assets Total 9.388M 10.318M 26.167M 17.071M 4.939M
Capital Lease Obligations 6.375M 7.124M 0.734M 1.585M -
Long Term Debt Total - - - - -

Cash Flow

(Currency in USD)
Breakdown 30-06-2023 30-06-2022 30-06-2021 30-06-2020 30-06-2019
Investments 9.698M 12.063M 4.061M -17.949M 1.415M
Total Cashflows From Investing Activities 9.698M 11.783M -7.265M -30.458M 1.17M
Total Cash From Financing Activities 8.024M 7.5M 61.402M 60.87M 23.582M
Net Income -28.887M -41.374M -49.865M -29.152M -35.307M
Change In Cash -5.157M -20.425M 22.609M 4.043M -4.701M
Begin Period Cash Flow 11.413M 31.838M 9.229M 5.186M 9.887M
End Period Cash Flow 6.256M 11.413M 31.838M 9.229M 5.186M
Total Cash From Operating Activities -22.857M -36.501M -30.91M -26.369M -29.453M
Depreciation 0.362M 1.053M 1.37M 1.57M 1.962M
Other Cashflows From Investing Activities - - -10.953M -12.239M -0.006M
Dividends Paid - - - - -
Change To Inventory - - - -0.789M -
Sale Purchase Of Stock - - - - -
Other Cashflows From Financing Activities 9.698M 7.5M 24.813M 2.707M 0.115M
Capital Expenditures 0.262M 0.28M 0.373M 0.27M 0.239M
Change In Working Capital 1.691M -5.089M 3.665M -1.338M -1.251M
Other Non Cash Items - - -0.048M -0.011M -0.003M
Free Cash Flow -23.119M -36.781M -31.283M -26.639M -29.692M

Funds

Sr. No. Name Purchased On Shares
1. I.B.I Up to 3 Years 90/10 IL 2 years ago 1967
2. Green Alpha Next Economy Social Index 2 years ago 1327
3. Dimensional International Small Cap ETF 2 years ago 124
4. BlueStar Israel Technology ETF 2 years ago 2
5. MTF TR TA-Growth 2 years ago 57298
6. DFA International Core Equity I 2 years ago 33473
7. Fidelity Nasdaq Composite Index 2 years ago 25169
8. I.B.I 80/20 2 years ago 23798
9. I.B.I 70/30 2 years ago 21807
10. IBI Mehaka TA-Growth 2 years ago 14213
11. DFA Intl Sustainability Core 1 2 years ago 5947
12. I.B.I Investment Portfolio 50/50 IL 2 years ago 5867
13. Harel HTF TA All-Share IL 2 years ago 4877
14. I.B.I GUY 75/25 IL 2 years ago 4628
15. I.B.I Up to 3 Years 90/10 IL 2 years ago 1967
16. Dimensional International Small Cap ETF 2 years ago 16

Institutions

Sr. No. Name Purchased On Shares
1. Renaissance Technologies Corp 2 years ago 190400
2. Values First Advisors Inc 2 years ago 149544
3. Meitav Dash Investments Ltd 2 years ago 73702
4. JANE STREET GROUP, LLC 2 years ago 32921
5. Geode Capital Management, LLC 2 years ago 25169
6. Zurcher Kantonalbank 2 years ago 21760
7. KESTRA PRIVATE WEALTH SERVICES, LLC 2 years ago 12000
8. Millennium Management LLC 2 years ago 11736
9. LPL Financial Corp 2 years ago 11140
10. Y.D. More Investments Ltd 2 years ago 10200
11. Morgan Stanley - Brokerage Accounts 2 years ago 6062
12. Banque Cantonale Vaudoise 2 years ago 3200
13. Altshuler Shaham Ltd 2 years ago 2520
14. UBS Group AG 2 years ago 2250
15. Wells Fargo & Co 2 years ago 1401
16. Bank of America Corp 2 years ago 1086
17. Royal Bank of Canada 2 years ago 1000
18. TD Waterhouse Canada Inc 2 years ago 740
19. Winch Advisory Services, LLC 2 years ago 206
20. Advisor Group Holdings, Inc. 2 years ago 200
Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Sponsored Articles

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
Open in the App